4131 related articles for article (PubMed ID: 6933263)
1. Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice.
Talmadge JE; Meyers KM; Prieur DJ; Starkey JR
J Natl Cancer Inst; 1980 Nov; 65(5):929-35. PubMed ID: 6933263
[TBL] [Abstract][Full Text] [Related]
2. The modulation of B16BL6 melanoma metastasis is not directly mediated by cytolytic activity of natural killer cells in alcohol-consuming mice.
Spitzer JH; Núñez NP; Meadows SA; Gallucci RM; Blank SE; Meadows GG
Alcohol Clin Exp Res; 2000 Jun; 24(6):837-44. PubMed ID: 10888072
[TBL] [Abstract][Full Text] [Related]
3. Genetic control of in vitro NK-activity and in vivo resistance to tumors.
Kärre K; Klein GO; Kiessling R; Klein G
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339
[TBL] [Abstract][Full Text] [Related]
4. Role of natural killer cells in intraocular melanoma metastasis.
Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N; Mizuno K
Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):516-8. PubMed ID: 3957568
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of hematogenous metastases in a murine model by natural killer cells.
Richie JP
Surgery; 1984 Aug; 96(2):133-8. PubMed ID: 6463854
[TBL] [Abstract][Full Text] [Related]
6. Relationship between rejection of several syngeneic tumors and retrovirus production by 5-bromodeoxyuridine-grown melanoma cells: lack of protection in natural killer-deficient beige mice.
Silagi S; Calvelli TA
Cancer Res; 1982 Jul; 42(7):2562-6. PubMed ID: 7083149
[TBL] [Abstract][Full Text] [Related]
7. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
[TBL] [Abstract][Full Text] [Related]
8. [In vivo metastasis of human tumor transplant in T and NK cell immune-deficient mice].
Wu BQ; Fang WG; Zheng J; Sun YK; Wang JL; Zhao XS; Yang JS; Lu CP; Sun J; Xu QM
Zhonghua Zhong Liu Za Zhi; 1988 Jan; 10(1):1-3. PubMed ID: 3262047
[TBL] [Abstract][Full Text] [Related]
9. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
Kalland T
Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of experimental tumor metastasis by selective activation of natural killer cells.
Hanna N
Cancer Res; 1982 Apr; 42(4):1337-42. PubMed ID: 6277482
[TBL] [Abstract][Full Text] [Related]
11. Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells.
Gorelik E; Fogel M; Feldman M; Segal S
J Natl Cancer Inst; 1979 Dec; 63(6):1397-404. PubMed ID: 292811
[TBL] [Abstract][Full Text] [Related]
12. Increased natural killer cell activity in experimental American trypanosomiasis.
Hatcher FM; Kuhn RE; Cerrone MC; Burton RC
J Immunol; 1981 Sep; 127(3):1126-30. PubMed ID: 6790614
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell activity is closely associated with a growth-inhibitory serum protein with protease-like activity.
Gundersen S; Funderud S; Bloom BR; Godal T
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):137-45. PubMed ID: 6410683
[TBL] [Abstract][Full Text] [Related]
14. Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment.
Ito D; Back TC; Shakhov AN; Wiltrout RH; Nedospasov SA
J Immunol; 1999 Sep; 163(5):2809-15. PubMed ID: 10453025
[TBL] [Abstract][Full Text] [Related]
15. Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects.
Fodstad O; Hansen CT; Cannon GB; Statham CN; Lichtenstein GR; Boyd MR
Cancer Res; 1984 Oct; 44(10):4403-8. PubMed ID: 6467201
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor effect of human interferon-alpha A/D in mice (II). Activation of natural killer cells and suppression of metastasis].
Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):510-5. PubMed ID: 2988456
[TBL] [Abstract][Full Text] [Related]
17. Resistance to intravenous tumor metastases in the athymic nude mouse: a paradoxic response.
Richie JP; McDonald J; Gittes RF
Surgery; 1981 Aug; 90(2):214-20. PubMed ID: 7256537
[TBL] [Abstract][Full Text] [Related]
18. Immune regulation of metastasis from in vivo derived syngeneic murine melanoma.
Harning R; Koo GC; Szalay J
Reg Immunol; 1990; 3(2):97-102. PubMed ID: 1965137
[TBL] [Abstract][Full Text] [Related]
19. Depression of natural antitumor resistance of C57BL/6 mice by leukemogenic doses of radiation and restoration of resistance by transfer of bone marrow or spleen cells from normal, but not beige, syngeneic mice.
Gorelik E; Herberman RB
J Natl Cancer Inst; 1982 Jul; 69(1):89-93. PubMed ID: 7047834
[TBL] [Abstract][Full Text] [Related]
20. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
